Psilocybin-Research.comSearchable psilocybin and psilocin bibliometric database.Researcher index
Authors in the psilocybin and psilocin literature
Search researcher names, inspect publication history, find recurring topics, and create author watch alerts without collecting unverified contact lists.
Publication history
Mindfulness-Based Psilocybin-Assisted Therapy (MB-PAT) for cancer-related demoralization in Canada: The case for a hybrid group-based delivery modelPsychedelics · 2026-12-01Serotonergic psychedelics induce distinct patterns of metabolic activity and covariance within biologically informed rat brain networksNature Communications · 2026-08-03Ethical Complexities and Best Practices in Informed Consent Processes for Psilocybin Services: A Qualitative StudyNeuroethics · 2026-08-01A cross-national comparison of nonmedical and medical use of psychedelic drugs in the international cannabis policy study.The International journal on drug policy · 2026-08-01Convergent neuroimmune signaling underlying rapid antidepressant response to ketamine and psychedelics.Molecular psychiatry · 2026-07-28No evidence for deleterious effects of psilocybin and MDMA on working memory or related neurophysiological activity in a non-clinical population: An uncontrolled exploratory studyJournal of Psychopharmacology · 2026-07-23The "dark magic mushroom" co-produces amatoxins and psilocybin.bioRxiv: the preprint server for biology · 2026-07-22Psilocybin as serotonergic therapy in epilepsy: Narrative review of potentials and limitationsBritish Journal of Clinical Pharmacology · 2026-07-21Psychedelics produce enduring enhancement of reward responsiveness in male rats.Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology · 2026-07-10α2-Adrenergic receptor modulates 5-HT2A-mediated behavioral effects of MDMA and psilocybin in miceMolecular Psychiatry · 2026-07-07Psilocybin restores behavior and 5-HT2A signaling while reducing microglial density after chronic traumatic brain injury in ratsCell Reports Medicine · 2026-07-01Efficacy of Psilocybin-Assisted Therapy in Major Depressive Disorder: A Systematic Review and Meta-AnalysisPsychiatry International · 2026-06-15Trials, trips, and tribulations: pathways for implementing psychedelic therapy in Ireland.The international journal of neuropsychopharmacology · 2026-06-02Hallucinogen-Assisted Psychotherapy for Trauma Disorders: A Bionian Lens.Psychodynamic psychiatry · 2026-06-01Long-Term Efficacy of Psilocybin with Adjunct Psychotherapy in Treatment-Resistant Major Depression: 6- and 12-Month Naturalistic Follow-Up of a Phase 2b TrialPsychotherapy and Psychosomatics · 2026-05-27Neural correlates of insight on psilocybin: a within-subjects, healthy volunteer studyJoCN Forum · 2026-05-08Prohedonic Effects of Psilocybin (COMP360) in a Touchscreen-Based Rodent Probabilistic Reward Task (Abstract ID: 227883)The Journal of Pharmacology and Experimental Therapeutics · 2026-05-01Insights from the psychedelic experience integration session: Verbatims differentiate 3-month abstinence in alcohol use disorder with depressive symptoms.Journal of affective disorders · 2026-05-01A randomized clinical trial of repeated doses of psilocybin for the treatment of obsessive-compulsive disorderJournal of Psychopharmacology · 2026-05-01Efficacy and Safety of Psilocybin in Treatment-Resistant Major DepressionJAMA Psychiatry · 2026-05-01Psychedelics and Autism Therapy: A Review of Current Research and Future Directions.Current issues in molecular biology · 2026-04-1826-CCC-15854-ACC TALK ABOUT A BAD TRIP!: PSILOCYBIN USE WITH PRE-EXISTING CARDIOVASCULAR DISEASE, A CASE REPORTJACC · 2026-04-01Psilocybin mitigates chronic behavioral and neurobiological alterations in a rat model of recurrent intimate partner violence-related brain injury.Molecular psychiatry · 2026-04-01Comparing single- and repeat-dose psilocybin with active placebo for migraine prevention in an exploratory randomized controlled clinical trial.Headache · 2026-04-01An international mega-analysis of psychedelic drug effects on brain circuit function.Nature medicine · 2026-04-01Associations Between Psilocybin Use Motives and Cognitive, Affective, and Behavioural Self-StigmaSubstance Use & Misuse · 2026-03-28Digital Intervention for Psychedelic Preparation (DIPP): protocol for a randomised controlled feasibility trial comparing meditation- and music-based programmes in healthy volunteers.BMJ open · 2026-03-12Delayed psilocybin treatment after repeated mild traumatic brain injury recovers chronic behavioural deficits, reduces microglial density, and enhances hippocampal neurogenesis in ratsResearch Square · 2026-02-23Ethical Complexities and Best Practices in Informed Consent for Psychedelic Services: A Qualitative Study on Expert PerspectivesPsyArXiv · 2026-02-19Mystical but Not Challenging Experiences Predict Symptom Improvement After Psilocybin for Treatment-Resistant OCDPsyArXiv · 2026-02-11Distinguishing 4- vs 5-Hydroxy- N, N -Dimethyltryptamine (Psilocin vs Bufotenine) Using Hydrogen-Deuterium Back-ExchangeJournal of the American Society for Mass Spectrometry · 2026-02-04Patient perspectives on research gaps in cluster headache.Headache · 2026-02-01Presence of 4-Hydroxy--methyl--ethyltryptamine in Commercially Available Products.ACS omega · 2026-01-20Development of Psilocybe Mushroom Species Reference Material-Cultivation Parameters and Chemical Profiles.Journal of AOAC International · 2026-01-01A novel psychedelic 5-HT receptor agonist GM-2505: The pharmacokinetic, safety, and pharmacodynamic profile from a randomized trial healthy volunteer.Journal of psychopharmacology (Oxford, England) · 2026-01-01Psilocybin-assisted psychotherapy for treatment-resistant obsessive-compulsive disorder: protocol for an open-label pilot study.BJPsych open · 2025-12-15Defining ‘psychedelic’PsyArXiv · 2025-12-04Towards "unmakable" psychedelics: SAR exploration of psilocin analogs obtained by a HATU-mediated amide coupling strategyEuropean Journal of Medicinal Chemistry Reports · 2025-12-01Short- and long-term modulation of rat prefrontal cortical activity following single doses of psilocybin.Molecular psychiatry · 2025-12-01Qualitative insights into psilocybin and LSD experiences: Enhanced connection and emotion processing reported by Spanish-speaking survey respondentsPsychedelics · 2025-11-15Psychedelic Augmentation of 12-Step Engagement: A Novel, Accessible Approach to Enhance Community-Based Recovery from Substance Use Disorders.Journal of psychoactive drugs · 2025-11-10[Acceptance of psilocybin-assisted therapy in German-speaking countries].Der Nervenarzt · 2025-11-01N,N-dimethyltryptamine effects on connectome harmonics, subjective experience and comparative psychedelic experiences.Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology · 2025-11-01Ethical challenges in the therapeutic application of classical psychedelics for pediatric health conditions: A comprehensive reviewBrazilian Journal of Science · 2025-09-29Ethical issues with psychedelic-assisted treatments in psychiatry: A systematic scoping review.Psychological medicine · 2025-09-29We may know why psilocybin helps treat mental health conditionsThe New Scientist · 2025-09-01Examining mystical experiences as a predictor of psilocybin-assisted psychotherapy for treatment-resistant depression.Journal of psychopharmacology (Oxford, England) · 2025-09-01Severe Rhabdomyolysis With Stage 3 Acute Kidney Injury After Ayahuasca Use Managed Without Renal Replacement Therapy: A Case Report.Cureus · 2025-09-01Examining the potential of psilocybin and 5-MeO-DMT as therapeutics for traumatic brain injury.Progress in neuro-psychopharmacology & biological psychiatry · 2025-08-30Psilocybin in alcohol use disorder and comorbid depressive symptoms: Results from a feasibility randomized clinical trial.Addiction (Abingdon, England) · 2025-07-24Exploring the Therapeutic Effects of Psychedelics Administered to Military Veterans in Naturalistic Retreat Settings.Brain and behavior · 2025-07-01Efficient Acyloxymethylation of Psilocin and Other Tryptamines Yielding ACOM Prodrugs for Psychedelic-Assisted TherapyArchiv der Pharmazie · 2025-07-01Caffeine, nicotine, cannabis, and psilocybin: Pharmacology, toxicology, and potential therapeutic uses of four naturally occurring psychoactive substances.Swiss medical weekly · 2025-07-01A Scoping Review of Research in Naturalistic Studies with Psychedelics.Journal of psychoactive drugs · 2025-06-28Under Pressure: Stronger depressive symptoms are associated with more positive expectations towards experimental treatmentsPsyArXiv · 2025-05-16Pharmacokinetics (PK) of psilocybin and psilocin in plasma following intravenous administration of psilocin and oral administration of psilocybin to male beagle dogsJournal of Pharmacological and Toxicological Methods · 2025-05-01Neurochemical characterization of 5-HTR partial agonists with simultaneous PET-MRI.Journal of cerebral blood flow and metabolism: official journal of the International Society of Cerebral Blood Flow and Metabolism · 2025-05-01ALSUntangled #77: Psilocybin.Amyotrophic lateral sclerosis & frontotemporal degeneration · 2025-05-01Anaesthetic implications of psilocybin and lysergic acid diethylamide: what is old is now new: A narrative review on psychedelics and anaesthesia.European journal of anaesthesiology · 2025-05-01Can the gut-brain axis provide insight into psilocybin's therapeutic value in reducing stress?Neurobiology of stress · 2025-05-01Precision Functional Mapping of Psilocybin’s Acute and Persistent Brain EffectsBiological Psychiatry · 2025-04-0913. Safety, Feasibility, and Tolerability of Psilocybin in Older Adults With Amnestic MCI: Preliminary Data From a SV2a PET Imaging StudyBiological Psychiatry · 2025-04-09595. Psilocybin-Assisted Therapy for Relapse Prevention in Alcohol Use Disorder: A RCTBiological Psychiatry · 2025-04-09Psilocybin-assisted Interpersonal Therapy for DepressionClinicalTrials.gov · 2025-04-09Psilocybin’s Effects on Headache Frequency are Not Related to Acute Psychedelic Effects or Measures of Mental Health: Secondary Analysis of Clinical Trials in Migraine and Cluster Headache (P7-12.001)Neurology · 2025-04-07Psilocybin-assisted therapy for relapse prevention in alcohol use disorder: a phase 2 randomized clinical trialUniversität Zürich, ZORA · 2025-04-01Improved LC-MS Detection of Opioids, Amphetamines, and Psychedelics Using TrEnDi.Journal of the American Society for Mass Spectrometry · 2025-03-05A Field-Wide Review and Analysis of Study Materials Used in Psilocybin Trials: Assessment of Two Decades of Research.Psychedelic medicine (New Rochelle, N.Y.) · 2025-03-01Akzeptanz psilocybin-assistierter Therapie in den deutschsprachigen Ländernedoc Publication server (Humboldt University of Berlin) · 2025-02-12High-quality draft genomes of ecologically and geographically diverse species.Microbiology resource announcements · 2025-02-11Oregon’s Emerging Psilocybin Services Workforce: An Environmental ScanDrug and Alcohol Dependence · 2025-02-01Crafting effective regulatory policies for psychedelics: What can be learned from the case of cannabis?Addiction (Abingdon, England) · 2025-02-01Australian psychologists' attitudes towards psychedelic-assisted therapy and training following a world-first drug down-scheduling.Drug and alcohol review · 2025-01-01A protocol for a scoping review of variations among psychedelic interventions for psychological suffering associated with the end-of-life.PloS one · 2025-01-01Disentangling debate about therapeutic and recreational use of psychedelicsAddiction · 2024-12-15Chronic pain education: past, present, and future of psychedelics for the management of chronic painPain Medicine · 2024-12-10Differential in Vitro Activation Profiles for Psychedelic versus Non-psychedelic Ergolines at the 5-HT2A ReceptorEmerging Trends in Drugs Addictions and Health · 2024-12-01Personal Psychedelic Experience as a Training Qualification for Facilitators: A Thematic Analysis of Qualitative Interviews with Psilocybin ExpertsPsyArXiv · 2024-10-31Increased reactivity of the paraventricular nucleus of the hypothalamus and decreased threat responding in male rats following psilocin administrationUNC Libraries · 2024-10-22Effect of psilocybin versus escitalopram on depression symptom severity in patients with moderate-to-severe major depressive disorder: observational 6-month follow-up of a phase 2, double-blind, randomised, controlled trial.EClinicalMedicine · 2024-10-01Psychedelic-assisted therapy for treating anxiety, depression, and existential distress in people with life-threatening diseases.The Cochrane database of systematic reviews · 2024-09-12Developing the Open Psychedelic Evaluation Nexus consensus measures for assessment of supervised psilocybin services: An e-Delphi study.Journal of psychopharmacology (Oxford, England) · 2024-08-01Psilocybin desynchronizes the human brain.Nature · 2024-08-01Engaging Mood Brain Circuits with Psilocybin (EMBRACE): a study protocol for a randomized, placebo-controlled and delayed-start, neuroimaging trial in depression.Trials · 2024-07-03Associations Between Harm Reduction Strategy Use and Acute Psychedelic Effects in Spanish Speakers who Used LSD or PsilocybinDrug and Alcohol Dependence · 2024-07-01Developing Core Consensus Measures for Assessment of Psilocybin ServicesDrug and Alcohol Dependence · 2024-07-01Historical Perspectives and Pharmacodynamic Actions of the Magic Mushroom (Psilocybin) for Future Global HealthcareTrends in Medical Research · 2024-06-28Impact of Psilocybin on Peripheral Cytokine Production.Psychedelic medicine (New Rochelle, N.Y.) · 2024-06-01Effect of MDMA-assisted therapy on mood and anxiety symptoms in advanced-stage cancer (EMMAC): study protocol for a double-blind, randomised controlled trial.Trials · 2024-05-21Psilocybin pulse regimen reduces cluster headache attack frequency in the blinded extension phase of a randomized controlled trial.Journal of the neurological sciences · 2024-05-15Comparing Neural Correlates of Consciousness: From Psychedelics to Hypnosis and Meditation.Biological psychiatry. Cognitive neuroscience and neuroimaging · 2024-05-01Psilocybin Exposures Reported to U.S. Poison Centers: National Trends Over a Decade.The Journal of adolescent health: official publication of the Society for Adolescent Medicine · 2024-05-01Psychedelics and the 'inner healer': Myth or mechanism?Journal of psychopharmacology (Oxford, England) · 2024-05-01In vitro and in vivo metabolism of psilocybin’s active metabolite psilocinFrontiers in Pharmacology · 2024-04-29Genetic regulation of L-tryptophan metabolism in Psilocybe mexicana supports psilocybin biosynthesis.Fungal biology and biotechnology · 2024-04-25Synthesis and bioactivity of psilocybin analogues containing a stable carbon-phosphorus bond.RSC medicinal chemistry · 2024-03-20Psilocybin-assisted psychotherapy for treatment resistant depression: A randomized clinical trial evaluating repeated doses of psilocybin.Med (New York, N.Y.) · 2024-03-08Effects of DMT on mental health outcomes in healthy volunteers.Scientific reports · 2024-02-07Rapid-acting antidepressant drugs modulate affective bias in rats.Science translational medicine · 2024-01-10Psychotherapy in Psychedelic Treatment: Safe, Evidence-Based, and NecessaryAmerican Journal of Psychiatry · 2024-01-01Psilocybin vs Escitalopram for depression: 6-month follow-upNeuroscience Applied · 2024-01-01Potential Benefits of Psilocybin for Lupus Pain: A Case Report.Current rheumatology reviews · 2024-01-01Misinterpretations and Omissions: A Critical Response to Goodwin and Colleagues' Commentary on Psilocybin-Assisted Therapy.The American journal of psychiatry · 2024-01-01Knowledge gaps in psychedelic medicalisation: Preclinical and neuroimaging mechanisms.Neuroscience applied · 2024-01-01Scoping Review: The Role of Psychedelics in the Management of Chronic Pain.Journal of pain research · 2024-01-01Within-subject comparison of near-death and psychedelic experiences: acute and enduring effects.Neuroscience of consciousness · 2024-01-01Translation and Initial Psychometric Evaluation of Spanish Versions of Three Psychedelic Acute Effects Measures: Mystical, Challenging, and Insight Experiences.Journal of psychoactive drugs · 2024-01-01Psilocybin-induced default mode network hypoconnectivity is blunted in alcohol-dependent rats.Translational psychiatry · 2023-12-14Domestication through clandestine cultivation constrained genetic diversity in magic mushrooms relative to naturalized populations.Current biology: CB · 2023-12-04Psilocybin for Opioid Use Disorder in Two Adults Stabilized on Buprenorphine: A Technical Report on Study Modifications and Preliminary Findings.Psychedelic medicine (New Rochelle, N.Y.) · 2023-12-01A protocol for a scoping review of psychedelic interventions to alleviate psychological suffering in populations coping with end-of-life issuesPsyArXiv · 2023-10-27Single-Dose Psilocybin Treatment for Major Depressive Disorder: A Randomized Clinical Trial.JAMA · 2023-09-05Psilocybin history, action and reaction: A narrative clinical review.Journal of psychopharmacology (Oxford, England) · 2023-09-01In vivo mapping of pharmacologically induced functional reorganization onto the human brain's neurotransmitter landscape.Science advances · 2023-06-16509. Meta-Analysis of Functional Neuroimaging Studies of the Effects of Serotonergic Psychedelics on Neural ActivityBiological Psychiatry · 2023-04-09To treat or not to treat? High-potency benzodiazepine use in a case of comorbid hallucinogen persisting perception disorder and alcohol use disorder.Experimental and clinical psychopharmacology · 2023-04-01Classic psychedelic use and current meditation practice.Mindfulness · 2023-04-01Yale Program for Psychedelic Science (YPPS) Manual for Psilocybin Combined with Non-Directive Support in the Treatment of OCDPsyArXiv · 2023-03-17Canalization and plasticity in psychopathology.Neuropharmacology · 2023-03-15[Attitudes of Mental Health Experts Towards Psilocybin].Fortschritte der Neurologie-Psychiatrie · 2023-03-01The Effects of Serotonergic Psychedelics on Neural Activity: A Meta-Analysis of Task-Based Functional Neuroimaging StudiesEuropean Psychiatry · 2023-02-28Body mass index (BMI) does not predict responses to psilocybin.Journal of psychopharmacology (Oxford, England) · 2023-01-01Among psychedelic-experienced users, only past use of psilocybin reliably predicts nature relatedness.Journal of psychopharmacology (Oxford, England) · 2023-01-01Biological embedding of early trauma: the role of higher prefrontal synaptic strength.European journal of psychotraumatology · 2023-01-01Exploring psilocybin-assisted psychotherapy in the treatment of methamphetamine use disorder.Frontiers in psychiatry · 2023-01-01Safety, tolerability, and clinical and neural effects of single-dose psilocybin in obsessive-compulsive disorder: protocol for a randomized, double-blind, placebo-controlled, non-crossover trial.Frontiers in psychiatry · 2023-01-01Group psychedelic therapy: empirical estimates of cost-savings and improved access.Frontiers in psychiatry · 2023-01-01Safety, feasibility, tolerability, and clinical effects of repeated psilocybin dosing combined with non-directive support in the treatment of obsessive-compulsive disorder: protocol for a randomized, waitlist-controlled trial with blinded ratings.Frontiers in psychiatry · 2023-01-01The psychedelic renaissance: the next trip for psychiatry?Irish journal of psychological medicine · 2022-12-01Single-dose psilocybin for treatment-resistant obsessive-compulsive disorder: A case report.Heliyon · 2022-12-01Structure-Activity Relationships for Psilocybin, Baeocystin, Aeruginascin, and Related Analogues to Produce Pharmacological Effects in Mice.ACS pharmacology & translational science · 2022-11-11Single-Dose Psilocybin for a Treatment-Resistant Episode of Major Depression.The New England journal of medicine · 2022-11-03The Watts Connectedness Scale: a new scale for measuring a sense of connectedness to self, others, and world.Psychopharmacology · 2022-11-01Exploratory investigation of a patient-informed low-dose psilocybin pulse regimen in the suppression of cluster headache: Results from a randomized, double-blind, placebo-controlled trial.Headache · 2022-11-01Yale Program for Psychedelic Science (YPPS) Manual for Psilocybin-OCD Session Monitors for Protocol HIC: 2000020355PsyArXiv · 2022-10-05Psilocybin use patterns and perception of risk among a cohort of Black individuals with Opioid Use Disorder.Journal of psychedelic studies · 2022-09-01Acute and long-term effects of psilocybin on energy balance and feeding behavior in mice.Translational psychiatry · 2022-08-11Assessment of Bioactivity-Modulating Pseudo-Ring Formation in Psilocin and Related TryptaminesChemBioChem · 2022-07-05Safety considerations in the evolving legal landscape of psychedelic-assisted psychotherapy.Substance abuse treatment, prevention, and policy · 2022-05-14Increased global integration in the brain after psilocybin therapy for depression.Nature medicine · 2022-04-01Psilocin acutely alters sleep-wake architecture and cortical brain activity in laboratory miceTranslational Psychiatry · 2022-02-23Psychedelic use predicts objective knowledge about climate change via increases in nature relatednessDrug Science Policy and Law · 2022-01-01Psychedelic philanthropy: The nonprofit sector and Timothy Leary's 1960s psychedelic movement.Journal of the history of the behavioral sciences · 2022-01-01Psychedelics and health behaviour change.Journal of psychopharmacology (Oxford, England) · 2022-01-01Effects of classic psychedelic drugs on turbulent signatures in brain dynamics.Network neuroscience (Cambridge, Mass.) · 2022-01-01Medicinal psychedelics for mental health and addiction: Advancing research of an emerging paradigm.The Australian and New Zealand journal of psychiatry · 2021-12-01A Complex Impact of Systemically Administered 5-HT2A Receptor Ligands on Conditioned Fear.The international journal of neuropsychopharmacology · 2021-09-21New Insights Into the Clinical and Nonclinical Effects of Psychedelic SubstancesEuropean Psychologist · 2021-09-17Naturalistic Entheogenics: Précis of Philosophy of PsychedelicsPsyArXiv · 2021-07-08Psychedelic science in post-COVID-19 psychiatry.Irish journal of psychological medicine · 2021-06-01New insights into the clinical and nonclinical effects of psychedelic substances: an integrative reviewPsyArXiv · 2021-05-05Psilocybin-Assisted Group Therapy and Attachment: Observed Reduction in Attachment Anxiety and Influences of Attachment Insecurity on the Psilocybin Experience.ACS pharmacology & translational science · 2021-04-09Acute and Sustained Reductions in Loss of Meaning and Suicidal Ideation Following Psilocybin-Assisted Psychotherapy for Psychiatric and Existential Distress in Life-Threatening Cancer.ACS pharmacology & translational science · 2021-04-09Ethical Concerns about Psilocybin Intellectual Property.ACS pharmacology & translational science · 2021-04-09Psychedelics and Health Behavior Change - Journal of Psychopharmacology (in press)PsyArXiv · 2021-03-24Anti-Inflammatory Effects of Four Psilocybin-Containing Magic Mushroom Water Extracts in vitro on 15-Lipoxygenase Activity and on Lipopolysaccharide-Induced Cyclooxygenase-2 and Inflammatory Cytokines in Human U937 Macrophage Cells.Journal of inflammation research · 2021-01-01Exploratory Controlled Study of the Migraine-Suppressing Effects of Psilocybin.Neurotherapeutics: the journal of the American Society for Experimental NeuroTherapeutics · 2021-01-01Psychedelic-Assisted Psychotherapy After COVID-19: The Therapeutic Uses of Psilocybin and MDMA for Pandemic-Related Mental Health Problems.Frontiers in psychiatry · 2021-01-01Effects and safety of Psilocybe cubensis and Panaeolus cyanescens magic mushroom extracts on endothelin-1-induced hypertrophy and cell injury in cardiomyocytes.Scientific reports · 2020-12-18DARK Classics in Chemical Neuroscience: NBOMes.ACS chemical neuroscience · 2020-12-02Psilocybin-assisted group therapy for demoralized older long-term AIDS survivor men: An open-label safety and feasibility pilot study.EClinicalMedicine · 2020-10-01Perceived harm, motivations for use and subjective experiences of recreational psychedelic 'magic' mushroom use.Journal of psychopharmacology (Oxford, England) · 2020-09-01Phytochemical, Cytotoxicity, Antioxidant and Anti-Inflammatory Effects of Magic Mushroom.Plants (Basel, Switzerland) · 2020-08-31Simultaneous Production of Psilocybin and a Cocktail of β-Carboline Monoamine Oxidase Inhibitors in "Magic" Mushrooms.Chemistry (Weinheim an der Bergstrasse, Germany) · 2020-01-13The Psilocybin-Telomere Hypothesis: An empirically falsifiable prediction concerning the beneficial neuropsychopharmacological effects of psilocybin on genetic aging.Medical hypotheses · 2020-01-01Self-Reported Illicit Drug Use Among Norwegian University and College Students. Associations With Age, Gender, and Geography.Frontiers in psychiatry · 2020-01-01Injury-Triggered Blueing Reactions of Psilocybe “Magic” MushroomsAngewandte Chemie · 2019-11-14The Varieties of Psychedelic EpistemologyUWA Profiles and Research Repository (University of Western Australia) · 2019-10-31Non-drug altered states as psychedelic experiencesGreenwich Academic Literature Archive (University of Greenwich) · 2019-08-15Psilocybin lacks antidepressant-like effect in the Flinders Sensitive Line rat.Acta neuropsychiatrica · 2019-08-01Psychedelic microdosing benefits and challenges: an empirical codebook.Harm reduction journal · 2019-07-10T137. Psilocybin-Assisted Group Therapy for Demoralization in Long-Term AIDS SurvivorsBiological Psychiatry · 2019-04-302018: A watershed year for psychedelic scienceDrug Science Policy and Law · 2019-01-01The Past and Future of Psychedelic Science: An Introduction to This Issue.Journal of psychoactive drugs · 2019-01-01Beyond LSD: A Broader Psychedelic Zeitgeist during the Early to Mid-20 Century.Journal of psychoactive drugs · 2019-01-01The Psychedelic Altered State of Consciousness: An Assessment of the Current Status of Psychedelic ResearchKTH Publication Database DiVA (KTH Royal Institute of Technology) · 2018-12-31DARK Classics in Chemical Neuroscience: Ibogaine.ACS chemical neuroscience · 2018-10-17High dose psilocybin is associated with positive subjective effects in healthy volunteers.Journal of psychopharmacology (Oxford, England) · 2018-07-01The hidden therapist: evidence for a central role of music in psychedelic therapy.Psychopharmacology · 2018-02-01Pharmacokinetics of Escalating Doses of Oral Psilocybin in Healthy Adults.Clinical pharmacokinetics · 2017-12-01NATURALIZING PSYCHEDELIC SPIRITUALITYZygon® · 2017-08-18Lifetime experience with (classic) psychedelics predicts pro-environmental behavior through an increase in nature relatedness.Journal of psychopharmacology (Oxford, England) · 2017-08-01MAGIC MUSHROOM AND ITS EFFECTIVENESSInternational Journal of Pharma and Bio Sciences · 2016-01-01Neurovascular and neuroimaging effects of the hallucinogenic serotonin receptor agonist psilocin in the rat brainNeuropharmacology · 2015-12-01Indoleamine Hallucinogens in Cluster Headache: Results of the Clusterbusters Medication Use Survey.Journal of psychoactive drugs · 2015-01-01Substance use initiation: the role of simultaneous polysubstance use.Drug and alcohol review · 2013-01-01Peak experiences of psilocybin users and non-users.Journal of psychoactive drugs · 2013-01-01Simultaneous polysubstance use among Danish 3,4-methylenedioxymethamphetamine and hallucinogen users: combination patterns and proposed biological bases.Human psychopharmacology · 2012-07-01Effects of the hallucinogenic drugs mescaline, phencyclidine and psilocybin on zebrafish behavior and physiologyThe FASEB Journal · 2012-04-01Alternative headache treatments: nutraceuticals, behavioral and physical treatments.Headache · 2011-03-01Heaven and hell--a phenomenological study of recreational use of 4-HO-MET in Sweden.Journal of psychoactive drugs · 2011-01-01Detection of Psilocybin Mushroom Analogs in ChocolateThe Chemical Educator · 2009-12-01Detection of Psilocybin Mushroom Analogs in Chocolate: Incorporating Current Events into the Undergraduate Teaching LaboratoryThe Chemical Educator · 2009-01-01Mismatch negativity generation in the human 5HT2A agonist and NMDA antagonist model of psychosis.Psychopharmacology · 2008-07-01[Automutilation after consumption of hallucinogenic mushrooms].Nederlands tijdschrift voor geneeskunde · 2007-12-29Safety, tolerability, and efficacy of psilocybin in 9 patients with obsessive-compulsive disorder.The Journal of clinical psychiatry · 2006-11-01Patterns of simultaneous polysubstance use in drug using university students.Human psychopharmacology · 2006-06-01Development of a psilocin immunoassay for serum and blood samplesInternational Journal of Legal Medicine · 2004-12-01Synthesis of a psilocin hapten and a protein-hapten conjugateJournal of Pharmacy and Pharmacology · 2002-09-01Presence of phenylethylamine in hallucinogenic Psilocybe mushroom: possible role in adverse reactions.Journal of analytical toxicology · 1998-01-01